ZNF408 activators are primarily chemicals that engage with transcriptional regulatory mechanisms, chromatin modification, and DNA methylation processes. Zinc-finger proteins, like ZNF408, often function in DNA-binding roles, transcriptional activities, or protein-protein interactions. Accordingly, the modulation of chromatin accessibility and the transcriptional landscape can indirectly influence the function or expression of ZNF408. For instance, compounds like RG108, which are DNA methyltransferase, can modify DNA methylation patterns. These changes in the DNA methylation landscape can impact the expression or DNA binding roles of ZNF408.
Histone modifications are central to transcriptional regulation and the accessibility of DNA for transcriptional machinery. In this context, of histone-modifying enzymes play a critical role. Mocetinostat and MS-275 are HDAC. By inhibiting histone deacetylation, they ensure a more relaxed chromatin state, affecting ZNF408's access to DNA or its transcriptional activity. Similarly, BIX-01294, EPZ-6438, UNC0638, and Chaetocin target histone methylation by inhibiting specific histone methyltransferases. Changes in histone methylation patterns can redirect the binding sites or the transcriptional activities of ZNF408. For instance, BIX-01294 and UNC0638, by inhibiting G9a/GLP, can alter histone H3 lysine 9 methylation, which is associated with transcriptional repression. Changes in these methylation marks can provide ZNF408 with new regulatory landscapes or modify its existing regulatory roles. Furthermore, the inhibition of histone acetyltransferases, such as P300/CBP by C646, modifies histone acetylation patterns. Histone acetylation is typically linked with transcriptional activation, so changes in these marks can influence ZNF408's DNA binding dynamics and its transcriptional outcomes. Collectively, these compounds highlight the intricacies of chromatin dynamics and transcriptional regulation. By modulating these pathways, one can indirectly influence the function and expression of DNA-binding proteins like ZNF408. While these activators don't directly bind or stimulate ZNF408, they create a cellular environment where ZNF408's roles in transcriptional regulation can be accentuated or redirected. As transcriptional and chromatin landscapes continuously evolve, understanding and targeting these pathways offer insights into the broader context of gene regulation and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
Inhibitor of G9a histone methyltransferase. By modifying histone methylation, it can influence ZNF408's transcriptional regulation mechanisms. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EZH2 inhibitor that affects histone methylation, potentially modulating the regions where ZNF408 binds or its transcriptional output. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor that changes DNA methylation patterns, potentially influencing ZNF408 expression or DNA binding. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor that alters chromatin accessibility, potentially affecting ZNF408's transcriptional regulatory roles. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor which can modify methylation patterns, influencing transcriptional regulation involving ZNF408. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Inhibitor of histone methyltransferase SUV39H1. Changes in histone methylation can impact ZNF408's transcriptional regulation mechanisms. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
Inhibitor of G9a/GLP histone methyltransferase, altering histone methylation patterns and potentially affecting ZNF408 function. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
P300/CBP histone acetyltransferase inhibitor. By altering histone acetylation, it can influence ZNF408's DNA binding or transcriptional activities. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
HDAC inhibitor that modulates chromatin structure, which might affect ZNF408's role in transcriptional regulation. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $256.00 $612.00 $936.00 | 2 | |
EZH2 inhibitor that affects histone methylation patterns, potentially influencing regions where ZNF408 binds or its transcriptional output. | ||||||